The MAPK/ERK signaling pathway is one more important target for inhibitors. This pathway is entailed in controling cell survival, growth, and differentiation. Inhibitors targeting MAPK/ERK are utilized in cancer cells treatments to avoid unrestrained cell spreading and lump growth. In a similar way, JAK/STAT signaling inhibitors modulate immune rea